These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 10448923)

  • 1. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
    Farzin D
    Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice.
    Zarrindast MR; Farzin D
    Eur J Pharmacol; 1996 Feb; 298(1):1-6. PubMed ID: 8867912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of dopamine receptor agents on naloxone-induced jumping behaviour in morphine-dependent mice.
    Zarrindast MR; Habibi M; Borzabadi S; Fazli-Tabaei S; Hossein Yahyavi S; Rostamin P
    Eur J Pharmacol; 2002 Sep; 451(3):287-93. PubMed ID: 12242090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
    Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
    Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the mechanism(s) of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice.
    Rezayat M; Azizi N; Zarrindast MR
    Pharmacol Toxicol; 1997 Sep; 81(3):124-9. PubMed ID: 9335069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal.
    Chartoff EH; Mague SD; Barhight MF; Smith AM; Carlezon WA
    J Neurosci; 2006 Jun; 26(24):6450-7. PubMed ID: 16775132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
    Zarrindast MR; Mohajeri S
    Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of morphine withdrawal signs by a D1 receptor agonist in the locus coeruleus of rats.
    Dizgah IM; Karimian SM; Zarrindast MR; Sohanaki H
    Neuroreport; 2005 Oct; 16(15):1683-6. PubMed ID: 16189477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice.
    Rodríguez-Arias M; Pinazo J; Miñarro J; Stinus L
    Pharmacol Biochem Behav; 1999 Sep; 64(1):123-30. PubMed ID: 10495006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dopamine in the expression of morphine withdrawal.
    el-Kadi AO; Sharif SI
    Gen Pharmacol; 1998 Apr; 30(4):499-505. PubMed ID: 9522166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice.
    Kuribara H
    Eur J Pharmacol; 1995 Mar; 275(3):251-8. PubMed ID: 7768292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
    Ohsawa M; Kamei J
    Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of MK-801 in morphine-dependent and non-dependent mice.
    Belozertseva I; Zvartau E; Bespalov A
    Life Sci; 1996; 58(4):PL55-61. PubMed ID: 8538362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
    Christensen D; Guilbaud G; Kayser V
    Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
    Walker EA; Sterious SN
    Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.
    Ary M; Cox B; Lomax P
    J Pharmacol Exp Ther; 1977 Feb; 200(2):271-6. PubMed ID: 557107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
    Yeh GC; Tao PL; Chen JY; Lai MC; Gao FS; Hu CL
    Eur J Pharmacol; 2002 Oct; 453(2-3):197-202. PubMed ID: 12398904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.
    Chartoff EH; Barhight MF; Mague SD; Sawyer AM; Carlezon WA
    Psychopharmacology (Berl); 2009 Jun; 204(2):227-39. PubMed ID: 19148621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adenosine receptor agents on the expression of morphine withdrawal in mice.
    Zarrindast MR; Naghipour B; Roushan-zamir F; Shafaghi B
    Eur J Pharmacol; 1999 Mar; 369(1):17-22. PubMed ID: 10204676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.